Equity Research Analyst with a passion for uncovering overlooked opportunities in biotech, technology, and special situation equities. At Pierce Capital Research, I’ve led deep-dive valuation work—from rNAV and RDCF models to live dashboards tracking intrinsic value—all aimed at helping investors make smarter, more informed decisions. I’m known for clear, high-impact research, thoughtful risk-reward framing, and a strong ability to translate complex financials into compelling investment narratives. Whether modeling pre-revenue biotech pipelines or assessing turnaround plays, I bring both rigor and intuition to every analysis.
NCAA III Basketball (4yrs)